Two Sigma Investments’s Edwards Lifesciences EW Stock Holding History

Two Sigma Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$769K	Buy	+9,600	New	+$791K	﹤0.01%	3446
2021 Q4	–	Sell	-6,200	Closed	-$702K	–	4440
2021 Q3	$702K	Sell	6,200 -5,300	-46%	-$605K	﹤0.01%	2950
2021 Q2	$1.19M	Buy	+11,500	New	+$1.08M	﹤0.01%	2326
2021 Q1	–	Sell	-7,900	Closed	-$721K	–	3938
2020 Q4	$721K	Buy	7,900 +1,800	+30%	+$149K	﹤0.01%	2237
2020 Q3	$487K	Buy	+6,100	New	+$476K	﹤0.01%	2271
2020 Q1	–	Sell	-28,800	Closed	-$2.24M	–	3313
2019 Q4	$2.24M	Buy	28,800 +7,800	+37%	+$609K	0.01%	1498
2019 Q3	$1.54M	Buy	21,000 +12,000	+133%	+$843K	0.01%	1630
2019 Q2	$554K	Buy	+9,000	New	+$544K	﹤0.01%	2417
2018 Q4	–	Sell	-5,400	Closed	-$313K	–	3133
2018 Q3	$313K	Sell	5,400 -53,700	-91%	-$2.63M	﹤0.01%	2748
2018 Q2	$2.87M	Buy	59,100 +48,000	+432%	+$2.24M	0.01%	1380
2018 Q1	$516K	Buy	+11,100	New	+$482K	﹤0.01%	2453
2016 Q4	–	Sell	-6,000	Closed	-$241K	–	3213
2016 Q3	$241K	Sell	6,000 -9,000	-60%	-$339K	﹤0.01%	2877
2016 Q2	$499K	Buy	+15,000	New	+$513K	﹤0.01%	2257

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Two Sigma Investments's EW Position: Q1 2026 in Review

Two Sigma Investments increased its Edwards Lifesciences (EW) stake by 169% in Q1 2026, buying an estimated $54.4M and bringing the position to 1,051,535 shares worth $84.2M. The position accounts for 0.07% of the portfolio, ranked #323.

Two Sigma Investments first reported a position in EW in Q3 2013 and has held it in 41 quarters since. The position peaked at $229M in Q4 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Two Sigma Investments held 1,051,535 shares of Edwards Lifesciences worth $84.2M as of Q1 2026.
Two Sigma Investments bought 660,149 Edwards Lifesciences shares in Q1 2026, an estimated $54.4M.
Edwards Lifesciences made up 0.07% of Two Sigma Investments's portfolio in Q1 2026, its #323 holding.
Two Sigma Investments first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 41 quarters since.
Two Sigma Investments's Edwards Lifesciences position peaked at $229M in Q4 2022.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.